Clinical Trials · NCT04329975
Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 1,087
- Start date
- May 2020
- Locations
- 1 site, Japan
- Primary endpoint
- Occurrence of Hyponatremia